Boxer Capital Management
Boxer Capital Management reported 47 stocks worth $1.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are TNGX (22.8%), KOD (12.2%) and RVMD (8.9%). Compared with Q2 2026, the fund opened new positions in ACHV, CCCC and TRAX, added to KYMR, REPL and SRZN, trimmed TNGX, ABVX and PGEN and sold out of VIR, PCVX and CRVS.
Latest filing: what Boxer Capital Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() TNGX Tango Therapeutics Inc | $263M | 22.8% | 10.5M | −350K (−3%) | 8 of 8 | |
| 2 | ![]() KOD Kodiak Sciences Inc | $140M | 12.2% | 1.5M | No change | 8 of 8 | |
| 3 | ![]() RVMD Revolution Medicines Inc | $103M | 8.9% | 500K | No change | 8 of 8 | |
| 4 | ![]() KYMR Kymera Therapeutics Inc | $58.6M | 5.1% | 525K | +95K (+22%) | 8 of 8 | |
| 5 | ![]() REPL Replimune Group Inc | $56.6M | 4.9% | 4.3M | +295K (+7%) | 8 of 8 | |
| 6 | ![]() ABVX Abivax SA | $47M | 4.1% | 475K | −130K (−21%) | 5 of 8 | |
| 7 | ![]() SRZN Surrozen Inc | $43.8M | 3.8% | 1.4M | +255K (+23%) | 4 of 8 | |
| 8 | ![]() CORT Corcept Therapeutics Inc | $38.7M | 3.4% | 336K | No change | 3 of 8 | |
| 9 | ![]() PGEN Precigen Inc | $37M | 3.2% | 4.3M | −830K (−16%) | 5 of 8 | |
| 10 | ![]() QURE Uniqure NV | $34.4M | 3.0% | 1.4M | −80K (−5%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() VIR Vir Biotechnology Inc | $19M | 1.9M |
![]() PCVX Vaxcyte Inc | $18.9M | 325K |
![]() CRVS Corvus Pharmaceuticals Inc | $16.4M | 1.1M |
![]() PTCT Ptc Therapeutics Inc | $16.3M | 200K |
![]() PRAX Praxis Precision Medicines I | $15.6M | 46K |
🔒 Free account: see all 28.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Boxer Capital Management 13F FAQ
What does Boxer Capital Management own?
Boxer Capital Management reported 47 stocks worth $1.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are TNGX (22.8%), KOD (12.2%) and RVMD (8.9%). The table above lists every position in the filing (the top 10 without an account).
What did Boxer Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 12 new positions, 9 added to, 13 trimmed and 28 sold out. New positions include ACHV, CCCC and TRAX. It sold all of VIR, PCVX and CRVS.
When will Boxer Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Boxer Capital Management's portfolio worth?
The Q3 2026 filing reports $1.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.
























